SG Americas Securities LLC increased its holdings in shares of Humana Inc. (NYSE:HUM – Free Report) by 434.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 410,634 shares of the insurance provider’s stock after purchasing an additional 333,794 shares during the period. SG Americas Securities LLC owned 0.34% of Humana worth $71,200,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in the stock. Pullen Investment Management LLC purchased a new position in shares of Humana in the 1st quarter valued at approximately $348,000. Hsbc Holdings PLC raised its stake in shares of Humana by 9.1% during the fourth quarter. Hsbc Holdings PLC now owns 330,794 shares of the insurance provider’s stock worth $85,107,000 after purchasing an additional 27,530 shares during the last quarter. Reflection Asset Management purchased a new stake in shares of Humana during the fourth quarter worth approximately $29,000. Invesco Ltd. lifted its holdings in shares of Humana by 9.3% during the fourth quarter. Invesco Ltd. now owns 2,233,130 shares of the insurance provider’s stock worth $571,972,000 after purchasing an additional 189,670 shares during the period. Finally, Corient Private Wealth LLC grew its position in Humana by 329.3% in the 4th quarter. Corient Private Wealth LLC now owns 120,104 shares of the insurance provider’s stock valued at $30,762,000 after buying an additional 92,125 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts have issued reports on HUM shares. TD Cowen boosted their price objective on shares of Humana from $173.00 to $211.00 and gave the company a “hold” rating in a research note on Friday, May 1st. William Blair started coverage on shares of Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating for the company. Weiss Ratings raised shares of Humana from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, June 12th. UBS Group reiterated a “neutral” rating on shares of Humana in a research note on Monday, June 15th. Finally, JPMorgan Chase & Co. increased their price target on shares of Humana from $214.00 to $316.00 and gave the stock a “neutral” rating in a report on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $291.35.
Humana Price Performance
Shares of NYSE HUM opened at $360.78 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. Humana Inc. has a one year low of $163.11 and a one year high of $380.86. The firm has a market capitalization of $43.32 billion, a P/E ratio of 38.59, a PEG ratio of 2.05 and a beta of 0.76. The company’s fifty day moving average is $289.14 and its two-hundred day moving average is $242.42.
Humana (NYSE:HUM – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s revenue was up 23.5% compared to the same quarter last year. During the same quarter last year, the firm posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. Analysts forecast that Humana Inc. will post 9.04 EPS for the current fiscal year.
Humana Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.0%. Humana’s payout ratio is currently 37.86%.
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Read More
- Five stocks we like better than Humana
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
